Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of SELLAS Life Sciences Group Inc (NASDAQ: SLS) was $1.62 for the day, up 4.52% from the previous closing price of $1.55. In other words, the price has increased by $4.52 from its previous closing price. On the day, 2.47 million shares were traded. SLS stock price reached its highest trading level at $1.665 during the session, while it also had its lowest trading level at $1.56.
Ratios:
Our analysis of SLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.72 and its Current Ratio is at 1.72. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.
On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLS now has a Market Capitalization of 153168416 and an Enterprise Value of 134286640.
Stock Price History:
The Beta on a monthly basis for SLS is 2.35, which has changed by 0.21804512 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, SLS has reached a high of $1.84, while it has fallen to a 52-week low of $0.77. The 50-Day Moving Average of the stock is 34.22%, while the 200-Day Moving Average is calculated to be 35.94%.
Shares Statistics:
SLS traded an average of 1.52M shares per day over the past three months and 1984970 shares per day over the past ten days. A total of 94.55M shares are outstanding, with a floating share count of 92.59M. Insiders hold about 2.08% of the company’s shares, while institutions hold 6.57% stake in the company. Shares short for SLS as of 1744675200 were 7774815 with a Short Ratio of 5.13, compared to 1741910400 on 7845644. Therefore, it implies a Short% of Shares Outstanding of 7774815 and a Short% of Float of 8.57.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current assessment of SELLAS Life Sciences Group Inc (SLS) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.08 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.35 and -$0.5 for the fiscal current year, implying an average EPS of -$0.42. EPS for the following year is -$0.44, with 3.0 analysts recommending between -$0.39 and -$0.53.
